D-1376-2015 Class III Terminated
FDA drug recall D-1376-2015 was initiated by Dr. Reddy's Laboratories, Inc. on Aug 13, 2015 and is designated Class III. Reason for recall: Subpotent Drug: Subpotent atorvastatin. The recall status is terminated (terminated Dec 15, 2016). Affected quantity: a) 14,640 and b) 624 Bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 2, 2015
- Initiation Date
- Aug 13, 2015
- Termination Date
- Dec 15, 2016
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- a) 14,640 and b) 624 Bottles
Product description
Amlodipine besylate and Atorvastatin calcium Tablets, 5 mg/20 mg, Packaged in a) 30 Count Bottles (NDC: 43598-319-30) and b) 90 Count Bottles (NDC: 43598-319-90), Rx Only. Manufactured by Dr. Reddy's Laboratories Limited, Bachupally - 500 090 India.
Reason for recall
Subpotent Drug: Subpotent atorvastatin.
Distribution pattern
U.S. Nationwide
Code information
a) Lot #: C403577, Expiry: 10/2015; b) Lot #: C403577, Expiry: 10/2015.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1376-2015
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026